{
    "title": "Lilly's breast cancer drug combination succeeds key study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4331078/Lillys-breast-cancer-drug-combination-succeeds-key-study.html",
    "date": "2017-03-20",
    "keywords": [
        "cancer",
        "breast",
        "combination",
        "drug",
        "abemaciclib",
        "data",
        "study",
        "market",
        "treatment",
        "antiestrogen",
        "ibrance",
        "therapy",
        "monotherapy",
        "society",
        "response",
        "grovermarch",
        "progression",
        "therapyin",
        "monitoring",
        "committee",
        "latestage",
        "modification",
        "evaluation",
        "part",
        "class",
        "pfizer",
        "incs",
        "novartis",
        "kisqalithe",
        "use",
        "fulvestrant",
        "monday",
        "addition",
        "lung",
        "improvement",
        "progressionfree",
        "drugmaker",
        "agent",
        "benefit",
        "application",
        "quarter",
        "quarterif",
        "entrant",
        "supportive",
        "safety",
        "approval",
        "client",
        "conference",
        "oncology",
        "asco",
        "meeting",
        "juneabemaciclib",
        "march",
        "rate",
        "duration",
        "tolerability",
        "diarrhea",
        "anderson",
        "forecast",
        "differentiation",
        "substantiallyafter",
        "skin",
        "disease",
        "control",
        "preventionabout",
        "morning",
        "tradingreporting",
        "grover",
        "bengaluru",
        "editing",
        "sai",
        "ravikumar",
        "martina",
        "dcouto"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}